Skip to content
value.today

Oncorus Inc.

ONCRUnlisted company
$7 Mlast known market cap, Dec 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2020 ending year
value.today research
Net income
$-57 M
value.today research
Employees
—

Oncorus Inc. in brief

Oncorus Inc. is an unlisted company in the Biotechnology industry, based in Massachusetts, USA. In the year to Dec 2020 it had sales of $0 M and a net loss of $57 M.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Oncorus Inc.

Oncorus is a Biopharmaceutical company focused on developing next generation, systemically active viral immunotherapies to transform outcomes for cancer patients. It is having 51 employees as on 2020. The headquarters is in USA.

Oncorus Inc. timeline

1 events, 2020
  1. 2020
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Oncorus Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Oncorus Inc.

Acquisitions and changes
No longer listed: ticker ONCR is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$197 M$395 M$592 M$789 M20212022

World rank over time

▼ down 22,936 places since 2021
2021-01-01: #9333#9,33320212022-01-07: #21664#21,66420222022-12-25: #32269#32,2692022

Rank in USA: #2,448 (Jan 2021) · #4,280 (Jan 2022) · #5,674 (Dec 2022)

Annual results

Revenue
$0 M
Operating income
—
Net income
$-57 M

Dec-2020 ending year

H-1B hiring at Oncorus Inc.#

1 labor condition applications certified in fiscal 2022 for 1 positions, at a median wage of $109 K a year.

Certified, FY2022
1
#2,088 among companies on value.today
Worker positions
1
Median wage offered
$109 K
a year, full-time
Applications filed
1
Oncorus Inc.: most frequent H-1B job titles in fiscal 2022
Job titlePositionsMedian wage offered
SCIENTISTBiological Scientists, All Other1$109 K

Where: Cambridge, MA 1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as ONCORUS, INC.

How Oncorus Inc. compares in Biotechnology

  • Revenue$0 M · higher than 0% of 647

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Oncorus Inc.🇺🇸$7 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Dec 25, 2022 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Oncorus Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Oncorus Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Oncorus Inc.? Suggest a correction